{"id":768640,"date":"2025-10-14T14:11:01","date_gmt":"2025-10-14T14:11:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=768640"},"modified":"2025-10-14T14:11:01","modified_gmt":"2025-10-14T14:11:01","slug":"singleuse-bioreactors-market-to-reach-usd-91-billion-by-2029","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/singleuse-bioreactors-market-to-reach-usd-91-billion-by-2029_768640.html","title":{"rendered":"Single-Use Bioreactors Market to Reach USD 9.1 Billion by 2029"},"content":{"rendered":"
\n
\"Single-Use<\/a><\/div>\n
\n
The global Single-Use Bioreactors (SUBs) Market is projected to grow from USD 4.4 billion in 2024 to USD 9.1 billion by 2029, at a CAGR of 15.4%.<\/div>\n<\/div>\n<\/div>\n
Single-use Bioreactors Market by Product (Systems, Bags, Assemblies), Type (Stirred Tank, Bubble-Column, Wave induced), Molecule (mAbs, Vaccines), Cell Type (Mammalian, Bacterial, Yeast), Application (R&D, Bioproduction) – Global Forecast to 2029<\/div>\n

Market growth is driven by the increasing adoption of single-use technologies<\/a><\/strong> among SMEs, CDMOs, and CMOs, along with the advantages of SUBs<\/strong> over traditional stainless-steel systems. These include lower capital costs, reduced water and energy usage, and greater flexibility<\/strong>.<\/p>\n

However, issues such as leachables and extractables<\/strong>, regulatory challenges<\/strong>, and PFAS restrictions<\/strong> may limit growth. Despite these challenges, the development of hybrid facilities<\/strong>—which combine traditional and single-use systems—presents strong opportunities for cost efficiency and flexibility.<\/p>\n

Download PDF Brochure: <\/strong>https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=49113750<\/strong><\/a><\/p>\n

A key concern for manufacturers remains the risk of bag breakage<\/strong>, which can cause contamination and financial losses.<\/p>\n

In 2023, single-use bioreactor systems<\/strong> and stirred-tank bioreactors<\/strong> dominated the market. North America<\/strong> led globally, supported by a strong biopharmaceutical R&D presence.<\/p>\n

Major players<\/strong> include Sartorius AG<\/strong>, Danaher Corporation<\/strong>, Thermo Fisher Scientific Inc.<\/strong>, and Merck KGaA<\/strong>.<\/p>\n

Key Players<\/strong><\/p>\n

Sartorius AG – Leading Provider of Single-Use Bioreactor Solutions<\/strong> Sartorius AG serves biopharmaceutical and pharmaceutical companies, CMOs, and CROs with a wide portfolio of high-quality, technology-driven SUB solutions<\/strong>. Strong R&D investments and global expansion have strengthened its market position, driving continued growth in the single-use bioreactors sector.<\/p>\n

Danaher Corporation – Innovator in Bioprocessing Technologies<\/strong> Through its subsidiary Cytiva<\/strong>, Danaher offers advanced solutions for cell culture, filtration, separation, and purification<\/strong>. Its single-use bioreactor technologies play a key role in drug, plasma, and vaccine production<\/strong>, making it a major force in the market.<\/p>\n

Thermo Fisher Scientific Inc. – Comprehensive Single-Use Solutions Provider<\/strong> Thermo Fisher offers an extensive range of single-use bioreactor products<\/strong> addressing diverse bioprocessing needs. Backed by strong market presence and R&D investments, the company continues to drive innovation and meet evolving industry demands.<\/p>\n

Market Segmentation Insights<\/strong><\/p>\n

By Product:<\/strong><\/p>\n